Abbott Announces Supply Agreement For Needlestick Prevention Products

Article

ABBOTT PARK, IL-Abbott Laboratories has signed a supply agreement for VanishPoint needlestick prevention products. VanishPoint products use patented automated retraction technology, which reduces exposure to contaminated needles.

Once a drug injection or blood draw is complete, the needle automatically retracts from the patient into the barrel of the device.

These products will become part of Abbott's Needlestick Prevention Systems product line.

Abbott already provides hospitals and healthcare facilities with VanishPoint blood collection tube holders under an 18-month agreement and VanishPoint retractable syringes as part of a two-year contract.

Abbott's products satisfy new OSHA prevention directives and the Needlestick Safety and Prevention Act, which became law November 2000.

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content